Ep 51. Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial
Update: 2025-08-13
Description
In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s.
Listen now to hear the findings and what this means for future clinical practice!
Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology.
Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
